Bicara Therapeutics Inc. · NASDAQ:BCAX
Mazumdar Claire sold 15,000 Bicara Therapeutics Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Mazumdar Claire (Director, Chief Executive Officer) sold 15,000 Bicara Therapeutics Inc. shares at an average US$20.04 for US$301K under a trading plan, leaving 362,152 shares. Filed May 20, 2026 (Form 4).
- Sold
- 15,000 shares
- Price
- US$20.04 average (US$19.96 to US$20.35)
- Value
- US$301K
- Holding after
- 362,152 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Option exercise | 15,000 | US$3.79 | 377,152 | Direct |
| May 18, 2026 | Common Stock | Sale | 12,022 | US$19.96 | 365,130 | Direct |
| May 18, 2026 | Common Stock | Sale | 2,978 | US$20.35 | 362,152 | Direct |
Source
Related
- Bicara Therapeutics Inc.
- Mazumdar Claire
- Bicara Therapeutics Inc. shareholders
- Form 4 · Mazumdar Claire · Aug 12, 2026
- Form 4 · Mazumdar Claire · Jul 14, 2026
- Form 4 · Mazumdar Claire · Apr 20, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Cohlhepp Ryan · Aug 12, 2026